Position in INVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,168,302
+$5,173,763 QoQ
Shares Held
350,571
+134.0% QoQ
Ownership
0.475%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 81.22149293581043.ToString("F0")%
Shared 0.ToString("F0")%
None 18.778507064189565.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. INVA ranks #85 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,168,302 | 350,571 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,994,539 | 149,802 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,996,073 | 218,963 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $5,010,403 | 249,398 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,274,142 | 290,907 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $4,934,094 | 284,386 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,165,869 | 578,243 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $8,301,743 | 506,204 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $2,093,349 | 137,359 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $5,280,479 | 329,207 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $4,159,409 | 320,201 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,101,286 | 322,175 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,374,245 | 299,933 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $4,446,380 | 335,576 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,588,160 | 309,058 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,564,517 | 377,000 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $5,936,519 | 306,797 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,823,374 | 279,616 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,034,778 | 241,459 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,467,069 | 333,115 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,383,103 | 199,423 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,841,635 | 148,639 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $452,045 | 43,258 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,873,513 | 134,014 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $368,687 | 31,351 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||